Lenalidomide plus rituximab produces durable responses in mantle cell lymphoma patients
Thursday, November 12, 2015 - 14:30
in Health & Medicine
The drug combination rituximab plus lenalidomide has been found to be effective and produced long-term responses in patients with mantle cell lymphoma, scientists report.